First Trust Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35M | Buy |
387,537
+73,053
| +23% | +$6.7M | 0.03% | 725 |
|
|
2025
Q4 | $28.3M | Sell |
314,484
-91,573
| -23% | -$8.68M | 0.02% | 772 |
|
|
2025
Q3 | $40M | Buy |
406,057
+156,388
| +63% | +$15.5M | 0.03% | 663 |
|
|
2025
Q2 | $22.8M | Sell |
249,669
-68,243
| -21% | -$6.6M | 0.02% | 854 |
|
|
2025
Q1 | $36M | Sell |
317,912
-6,561
| -2% | -$702K | 0.03% | 670 |
|
|
2024
Q4 | $34.3M | Buy |
324,473
+24,671
| +8% | +$2.65M | 0.03% | 674 |
|
|
2024
Q3 | $32.4M | Buy |
299,802
+68,335
| +30% | +$7.46M | 0.03% | 640 |
|
|
2024
Q2 | $25.1M | Buy |
231,467
+121,565
| +111% | +$14.3M | 0.03% | 701 |
|
|
2024
Q1 | $14.5M | Sell |
109,902
-57,071
| -34% | -$7.13M | 0.01% | 906 |
|
|
2023
Q4 | $20.3M | Buy |
166,973
+71,806
| +75% | +$8.01M | 0.02% | 766 |
|
|
2023
Q3 | $10.7M | Buy |
95,167
+8,044
| +9% | +$1.02M | 0.01% | 968 |
|
|
2023
Q2 | $12.7M | Sell |
87,123
-45,660
| -34% | -$6.21M | 0.01% | 929 |
|
|
2023
Q1 | $17.2M | Buy |
132,783
+54,301
| +69% | +$6.82M | 0.02% | 802 |
|
|
2022
Q4 | $10M | Buy |
78,482
+12,481
| +19% | +$1.45M | 0.01% | 959 |
|
|
2022
Q3 | $6.9M | Sell |
66,001
-49,113
| -43% | -$5.39M | 0.01% | 1063 |
|
|
2022
Q2 | $12.1M | Sell |
115,114
-116,361
| -50% | -$13.8M | 0.01% | 886 |
|
|
2022
Q1 | $29.6M | Buy |
231,475
+83,908
| +57% | +$10.1M | 0.03% | 656 |
|
|
2021
Q4 | $18.2M | Buy |
147,567
+33,061
| +29% | +$4.33M | 0.02% | 880 |
|
|
2021
Q3 | $16.3M | Buy |
114,506
+69,715
| +156% | +$10.3M | 0.02% | 849 |
|
|
2021
Q2 | $6.99M | Buy |
+44,791
| New | +$7.26M | 0.01% | 1136 |
|
|
2021
Q1 | – | Sell |
-4,437
| Closed | -$664K | – | 2469 |
|
|
2020
Q4 | $664K | Buy |
+4,437
| New | +$627K | ﹤0.01% | 2042 |
|
|
2020
Q3 | – | Sell |
-93,908
| Closed | -$10.9M | – | 2500 |
|
|
2020
Q2 | $10.9M | Buy |
93,908
+90,414
| +2,588% | +$10.4M | 0.02% | 710 |
|
|
2020
Q1 | $343K | Sell |
3,494
-3,463
| -50% | -$454K | ﹤0.01% | 2055 |
|
|
2019
Q4 | $1.01M | Buy |
6,957
+2,897
| +71% | +$400K | ﹤0.01% | 1881 |
|
|
2019
Q3 | $541K | Buy |
4,060
+77
| +2% | +$9.95K | ﹤0.01% | 2091 |
|
|
2019
Q2 | $455K | Sell |
3,983
-350,999
| -99% | -$41.1M | ﹤0.01% | 2164 |
|
|
2019
Q1 | $44M | Buy |
354,982
+38,361
| +12% | +$4.36M | 0.09% | 294 |
|
|
2018
Q4 | $31.9M | Buy |
316,621
+111,210
| +54% | +$12.5M | 0.08% | 330 |
|
|
2018
Q3 | $26.2M | Sell |
205,411
-7,923
| -4% | -$942K | 0.05% | 489 |
|
|
2018
Q2 | $23.1M | Buy |
213,334
+140,976
| +195% | +$15.3M | 0.05% | 507 |
|
|
2018
Q1 | $7.66M | Sell |
72,358
-3,779
| -5% | -$439K | 0.02% | 855 |
|
|
2017
Q4 | $8.92M | Buy |
76,137
+64,145
| +535% | +$7.25M | 0.02% | 810 |
|
|
2017
Q3 | $1.36M | Sell |
11,992
-98,275
| -89% | -$11.3M | ﹤0.01% | 1699 |
|
|
2017
Q2 | $13.7M | Buy |
110,267
+19,429
| +21% | +$2.3M | 0.04% | 633 |
|
|
2017
Q1 | $10.8M | Sell |
90,838
-72,096
| -44% | -$8.17M | 0.03% | 728 |
|
|
2016
Q4 | $16.3M | Sell |
162,934
-49,785
| -23% | -$5.34M | 0.05% | 544 |
|
|
2016
Q3 | $26.9M | Buy |
212,719
+17,241
| +9% | +$2.13M | 0.08% | 322 |
|
|
2016
Q2 | $22.8M | Buy |
195,478
+132,577
| +211% | +$15M | 0.07% | 358 |
|
|
2016
Q1 | $6.51M | Buy |
+62,901
| New | +$6.08M | 0.02% | 848 |
|
|
2015
Q3 | – | Sell |
-185,796
| Closed | -$19.7M | – | 2342 |
|
|
2015
Q2 | $19.7M | Buy |
185,796
+18,221
| +11% | +$2.02M | 0.05% | 443 |
|
|
2015
Q1 | $19.1M | Sell |
167,575
-127,207
| -43% | -$14.5M | 0.06% | 439 |
|
|
2014
Q4 | $32.5M | Sell |
294,782
-71,368
| -19% | -$7.52M | 0.11% | 223 |
|
|
2014
Q3 | $35.7M | Buy |
366,150
+9,594
| +3% | +$944K | 0.14% | 152 |
|
|
2014
Q2 | $36M | Buy |
356,556
+33,435
| +10% | +$3.26M | 0.15% | 154 |
|
|
2014
Q1 | $29.7M | Buy |
323,121
+40,960
| +15% | +$3.78M | 0.13% | 183 |
|
|
2013
Q4 | $25.5M | Sell |
282,161
-41,439
| -13% | -$3.59M | 0.12% | 185 |
|
|
2013
Q3 | $25.8M | Buy |
323,600
+40,054
| +14% | +$3.15M | 0.14% | 154 |
|
|
2013
Q2 | $20.6M | Buy |
+283,546
| New | +$21.2M | 0.13% | 181 |
|
Other funds holding ZBH
VCM
VPM
First Trust Advisors's ZBH Position: Q1 2026 in Review
First Trust Advisors increased its Zimmer Biomet (ZBH) stake by 23% in Q1 2026, buying an estimated $6.7M and bringing the position to 387,537 shares worth $35M. The position accounts for 0.03% of the portfolio, ranked #725.
First Trust Advisors first reported a position in ZBH in Q2 2013 and has held it in 48 quarters since. The position peaked at $44M in Q1 2019. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- First Trust Advisors held 387,537 shares of Zimmer Biomet worth $35M as of Q1 2026.
- First Trust Advisors bought 73,053 Zimmer Biomet shares in Q1 2026, an estimated $6.7M.
- Zimmer Biomet made up 0.03% of First Trust Advisors's portfolio in Q1 2026, its #725 holding.
- First Trust Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 48 quarters since.
- First Trust Advisors's Zimmer Biomet position peaked at $44M in Q1 2019.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.